|
ASCC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.020400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.552000E-01 |
| Normal-vs-Stage2 |
7.958400E-01 |
| Normal-vs-Stage3 |
6.734400E-02 |
| Normal-vs-Stage4 |
1.390440E-01 |
| Stage1-vs-Stage2 |
2.586000E-01 |
| Stage1-vs-Stage3 |
3.350300E-04 |
| Stage1-vs-Stage4 |
3.299800E-03 |
| Stage2-vs-Stage3 |
2.505800E-01 |
| Stage2-vs-Stage4 |
3.588800E-01 |
| Stage3-vs-Stage4 |
7.888000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.551400E-01 |
| Normal-vs-AfricanAmerican |
1.422220E-02 |
| Normal-vs-Asian |
3.295800E-01 |
| Caucasian-vs-AfricanAmerican |
8.924400E-03 |
| Caucasian-vs-Asian |
4.112600E-01 |
| AfricanAmerican-vs-Asian |
4.642000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.288600E-01 |
| Normal-vs-Female |
8.078600E-01 |
| Male-vs-Female |
9.400600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.487800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.549600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.149800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.449400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.146400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.495000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.521200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.606600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.587200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.711800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.881570E-01 |
| Normal-vs-Grade 2 |
2.051400E-01 |
| Normal-vs-Grade 3 |
1.995600E-01 |
| Normal-vs-Grade 4 |
3.048600E-01 |
| Grade 1-vs-Grade 2 |
5.465200E-01 |
| Grade 1-vs-Grade 3 |
7.578200E-02 |
| Grade 1-vs-Grade 4 |
1.454350E-01 |
| Grade 2-vs-Grade 3 |
4.986300E-04 |
| Grade 2-vs-Grade 4 |
2.978200E-02 |
| Grade 3-vs-Grade 4 |
9.770200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.256100E-02 |
| Normal-vs-ccB subtype |
1.191440E-01 |
| ccA subtype-vs-ccB subtype |
2.41970000000036E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.779600E-01 |
| Normal-vs-N1 |
7.680400E-01 |
| N0-vs-N1 |
6.330200E-01 |
|
|
